Skip to main content
Signal8

Roche Holding AG (RHHBY)

Sector: Drug Manufacturers - General

Industry: Drug Manufacturers - General

Roche Holding AG logo

Roche Holding AG

OTC:RHHBYHealthcare
-1.15%$60.25
CLOSED
AH$60.25+0.00%vs close
Mkt Cap$384.04B
EV-
Float646.17M
O/S6.37B
VOL2.13M sh
$ Vol$128.62M
RVOL1.47×
Inst Own-
SI0.5%
Net Cash/Sh-
EarningsFeb 4 · in 3mo
Div Yield2.57%
Dilution
Roche Holding AG logoOTC:RHHBYClosed$60.25-1.15%
Historical Data
DateOpenHighLowCloseVolume
Nov 17, 202660.1760.9160.1260.252,126,965
Nov 16, 202660.9961.2760.8060.951,544,131
Nov 13, 202660.1560.4960.0560.30617,955
Nov 12, 202660.7560.9860.4760.50977,801
Nov 11, 202660.0160.7059.8760.57724,682
Nov 10, 202660.9661.2260.5861.08723,757
Nov 9, 202660.8161.7560.4961.32861,205
Nov 6, 202658.3259.6158.2059.371,096,381
Nov 5, 202659.7660.4059.3359.45981,495
Nov 4, 202660.2861.0459.8860.941,118,542
Nov 3, 202660.4360.5859.1359.181,132,298
Nov 2, 202660.4860.7660.2260.672,091,787
Oct 30, 202661.1061.4460.7561.271,523,441
Oct 29, 202660.5661.0360.5160.771,148,667
Oct 28, 202659.4660.2859.3960.221,274,744
Oct 27, 202659.4260.3759.4160.372,544,554
Oct 26, 202659.8260.1559.7059.983,624,604
Oct 23, 202659.5361.4959.0061.172,699,576
Oct 22, 202658.6559.8358.4159.62979,287
Oct 21, 202659.1459.4958.8359.111,353,176
Analyst Coverage
Analyst Coverage
ConsensusHold
Price Target
Not available
Ratings Distribution
BUY
3
HOLD
5
SELL
1
TOTAL9
About

Roche Holding AG functions as a major global healthcare enterprise, primarily concentrating its efforts within the pharmaceutical and diagnostic sectors.

The company boasts an extensive international presence, with key operations located in countries such as Switzerland, Germany, the United States, Austria, the Netherlands, the United Kingdom, France, and Belgium.

Its pharmaceutical division is dedicated to creating and supplying a diverse array of therapeutic remedies. These target a broad spectrum of medical fields, including oncology, neuroscience, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments. The comprehensive product line further extends to treatments for specific conditions like infectious diseases, anemia, various dermatological issues, hemophilia, inflammatory and autoimmune disorders, neurological conditions, and transplantation-related needs. Within its diagnostics segment, Roche develops and markets a wide variety of laboratory-based tests designed to identify and monitor numerous illnesses. These include, but are not limited to, cancer, diabetes, Covid-19, hepatitis, and human papillomavirus.

Additionally, the company is a provider of essential diagnostic instruments and reagents. Established in 1896, Roche Holding AG maintains its corporate headquarters in Basel, Switzerland.

Key Metrics
Market Cap$384.04B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership--

based on 6.37B shares outstanding

SectorHealthcare
IndustryDrug Manufacturers - General
ExchangeOTC
CountryCHCH
IPO DateAug 20, 2003
Shares Outstanding6.37B
Authorized Shares
Float646.17M
52-Week Range
$47.05$61.75
$60.25(90th percentile)
Volume
Average Daily Volume1.44M
2.13M today vs 1.44M avg(+47%)

30d Avg

1.44M

60d Avg

1.45M

90d Avg

1.68M

Earnings
Dividend History
TTM Yield
2.57%
Paid annually
Annual (LTM)
$1.55
Latest
$1.5495
Mar 13, 26
5Y Growth
+4.89%
per year

1 member of Congress disclosed 1 trade in RHHBY with transaction dates in the 180 days to Nov 18, 2026. Roche Holding AG (OTC: RHHBY) traded at $60.25 on Nov 17, 2026, down 1.15% from the previous close of $60.95. 52-week range: $47.05 to $61.75. The company is in the Healthcare sector (Drug Manufacturers - General).